Catalyst Wire Dossier Catalyst Wire Dossier

Egrifta

tesamorelin · Theratechnologies
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Egrifta, covering 2012-06-26 to 2018-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA® [Phase 4]

See pricing